Article Information
History
- April 18, 2023.
Article Versions
- Version 1 (January 17, 2023 - 11:43).
- Version 2 (January 30, 2023 - 14:54).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ryan Yermus, MD1,
- Michael Verbora, MBA, MD1,2,
- Sidney Kennedy, MD3,
- Robert McMaster, MD3,
- Sarah Kratina, BScN, RN4,
- Elizabeth Wolfson, PhD1,
- Ben Medrano, MD7,8,
- Nathan Bryson, PhD9,
- Nabid Zaer, MD1,10,
- John Bottos1,
- Varun Setlur1 and
- Chris Lo, PhD3,5,6,*
- 1Field Trip Health, Toronto, Ontario
- 2Family Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario
- 3Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario
- 4Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario
- 5Social and Behavioural Health Sciences Division, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario
- 6Psychology, School of Social and Health Sciences, James Cook University, Singapore
- 7Field Trip Health NY & DC, New York, NY & Washington, District of Colombia
- 8Nue Life Medical Group, Delaware
- 9Reunion Neuroscience, Toronto, Ontario
- 10School of Biological Sciences and Applied Chemistry, Seneca College, Toronto, Ontario
- ↵*Corresponding Author
Chris Lo PhD, School of Social and Health Sciences, James Cook University, 149 Sims Dr. Singapore 387380. Email: chris.lo{at}utoronto.ca.
Posted April 18, 2023.
Ketamine-assisted psychotherapy provides lasting and effective results in the treatment of depression, anxiety and post traumatic stress disorder at 3 and 6 months: Findings from a large single-arm retrospective effectiveness trial
